
For decades, developers and regulators of vaccines and other biological products have been concerned about the theoretical risk to patients posed by zzso derived from the cell zzso used to produce those zzso The present study addresses the issue of how risky DNA may be as a residual zzso by injecting both normal and zzso monkeys with zzso zzso zzso of DNA from a human tumor cell zzso After more than eight years of zzso none of the animals shows evidence of zzso zzso The results of this study along with clinical experiences with already approved products derived from continuous cell lines suggest that he benefits of using such cells for the production of zzso far outweigh any theoretical risks associated with zzso 

